Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Michael Harned & Paul Sloan. (2016) Safety concerns with long-term opioid use. Expert Opinion on Drug Safety 15:7, pages 955-962.
Read now
Read now
Wouter F. W. Kappelle, Peter D. Siersema, Auke Bogte & Frank P. Vleggaar. (2016) Challenges in oral drug delivery in patients with esophageal dysphagia. Expert Opinion on Drug Delivery 13:5, pages 645-658.
Read now
Read now
Howard S Smith. (2013) Considerations in selecting rapid-onset opioids for the management of breakthrough pain. Journal of Pain Research 6, pages 189-200.
Read now
Read now
Mellar P Davis. (2011) Fentanyl for breakthrough pain: a systematic review. Expert Review of Neurotherapeutics 11:8, pages 1197-1216.
Read now
Read now
S.R. Nalamachu, A. Narayana & L. Janka. (2011) Long-term dosing, safety, and tolerability of fentanyl buccal tablet in the management of noncancer-related breakthrough pain in opioid-tolerant patients. Current Medical Research and Opinion 27:4, pages 751-760.
Read now
Read now
Enno Freye. (2009) A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet. Journal of Pain Research 2, pages 13-20.
Read now
Read now
Peter Watts & Alan Smith. (2009) PecSys: in situ gelling system for optimised nasal drug delivery. Expert Opinion on Drug Delivery 6:5, pages 543-552.
Read now
Read now
Mona Darwish & John Messina. (2008) Clinical pharmacology of fentanyl buccal tablet for the treatment of breakthrough pain. Expert Review of Clinical Pharmacology 1:1, pages 39-47.
Read now
Read now
Donald R Taylor. (2007) Fentanyl buccal tablet: rapid relief from breakthrough pain. Expert Opinion on Pharmacotherapy 8:17, pages 3043-3051.
Read now
Read now
Articles from other publishers (74)
Diana González-Bermejo, Belén Castillo-Cano, Alfonso Rodríguez-Pascual, Pilar Rayón-Iglesias, Dolores Montero-Corominas & Consuelo Huerta-Álvarez. (2023) Dynamic relationship among immediate release fentanyl use and cancer incidence: A multivariate time-series analysis using vector autoregressive models. Research Methods in Medicine & Health Sciences.
Crossref
Crossref
Jonathan L. Fu & Michael D. Perloff. (2022) Pharmacotherapy for Spine-Related Pain in Older Adults. Drugs & Aging 39:7, pages 523-550.
Crossref
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
511
774
.
Stefan Wirz, Michael Schenk, Hannes Hofbauer, Hans-Christian Wartenberg, Marco Cascella & Kristin Kieselbach. (2020) Nicht-indikationsgemäßer Einsatz schnell freisetzender FentanylzubereitungenUse of rapid-onset fentanyl preparations beyond indication. Der Schmerz 35:2, pages 114-123.
Crossref
Crossref
Diana González‐Bermejo, Pilar Rayón‐Iglesias, Alfonso Rodríguez‐Pascual, Arturo Álvarez‐Gutiérrez, Ana Fernández‐Dueñas, Dolores Montero‐Corominas & Consuelo Huerta‐Álvarez. (2020) Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication. Pharmacoepidemiology and Drug Safety 30:3, pages 371-378.
Crossref
Crossref
Sigal Kaplan, Aurore Bergamasco, Martin Sergerie, Anne-Marie Castilloux & Yola Moride. (2019) Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web Surveillance. Drug Safety 43:2, pages 163-177.
Crossref
Crossref
Tess M. Kilwein, Preston Hunt & Alison Looby. (2018) A Descriptive Examination of Nonmedical Fentanyl Use in the United States: Characteristics of Use, Motives, and Consequences. Journal of Drug Issues 48:3, pages 409-420.
Crossref
Crossref
. 2018. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
447
696
.
Samir Sheth, Mark Holtsman & Gagan Mahajan. 2018. Essentials of Pain Medicine. Essentials of Pain Medicine
373
384.e2
.
David Hui, Kelly Kilgore, Susan Frisbee-Hume, Minjeong Park, Diane Liu, Diwakar D. Balachandran & Eduardo Bruera. (2017) Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial. Journal of Pain and Symptom Management 54:6, pages 798-805.
Crossref
Crossref
Charles A Odonkor, Gabriel Kim & Michael Erdek. (2017) Global cancer pain management: a systematic review comparing trials in Africa, Europe and North America. Pain Management 7:4, pages 299-310.
Crossref
Crossref
Kasey L. Malotte & Hunter Groninger. (2017) Comparison of Fentanyl Oral and Nasal Formulations #331. Journal of Palliative Medicine 20:7, pages 784-786.
Crossref
Crossref
Kenneth S. Tseng & Lucy L. Chen. (2016) Opioid Therapy for Long-Term Pain Control in Non-terminal Patients. Current Anesthesiology Reports 6:4, pages 305-313.
Crossref
Crossref
Boaz Gedaliahu Samolsky Dekel, Francesca Remondini, Alberto Gori, Alessio Vasarri, GianFranco Di Nino & Rita Maria Melotti. (2016) Development, validation and psychometric properties of a diagnostic/prognostic tool for breakthrough pain in mixed chronic-pain patients. Clinical Neurology and Neurosurgery 141, pages 23-29.
Crossref
Crossref
Sean W. Moore & Jeffrey Freeman. 2016. Treating Comorbid Opioid Use Disorder in Chronic Pain. Treating Comorbid Opioid Use Disorder in Chronic Pain
185
198
.
Robert Froud, Tom Bjørkli, Philip Bright, Dévan Rajendran, Rachelle Buchbinder, Martin Underwood, David Evans & Sandra Eldridge. (2015) The effect of journal impact factor, reporting conflicts, and reporting funding sources, on standardized effect sizes in back pain trials: a systematic review and meta-regression. BMC Musculoskeletal Disorders 16:1.
Crossref
Crossref
Manuel Heim. (2015) Noninterventional Study of Transdermal Fentanyl (Fentavera) Matrix Patches in Chronic Pain Patients: Analgesic and Quality of Life Effects. Pain Research and Treatment 2015, pages 1-9.
Crossref
Crossref
Annette O. Arthur, Nasir Mushtaq, Shannon Mumma & Stephen H. Thomas. (2015) Fentanyl buccal tablet versus oral oxycodone for Emergency Department treatment of musculoskeletal pain. Journal of Emergency Medicine, Trauma and Acute Care 2015:1.
Crossref
Crossref
C. Takigawa, F. Goto, S. Tanda, Y. Shima, K. Yomiya, M. Matoba, I. Adachi, T. Yoshimoto & K. Eguchi. (2014) Breakthrough pain management using fentanyl buccal tablet (FBT) in combination with around-the-clock (ATC) opioids based on the efficacy and safety of FBT, and its relationship with ATC opioids: results from an open-label, multi-center study in Japanese cancer patients with detailed evaluation. Japanese Journal of Clinical Oncology 45:1, pages 67-74.
Crossref
Crossref
. 2015. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
417
651
.
Chandra Sekhar Kolli & Indiran Pather. 2015. Oral Mucosal Drug Delivery and Therapy. Oral Mucosal Drug Delivery and Therapy
125
148
.
Matthew S Thiese, Kurt T Hegmann, Eric M Wood, Arun Garg, J Steven Moore, Jay Kapellusch, James Foster & Ulrike Ott. (2014) Prevalence of low back pain by anatomic location and intensity in an occupational population. BMC Musculoskeletal Disorders 15:1.
Crossref
Crossref
V. Osborne, D. Layton, C. Fogg, M. Al-Shukri & S.A.W. Shakir. (2014) Utilization of fentanyl buccal tablets in England: Exploring off-label use reported in a cohort study. European Journal of Pain 18:4, pages 506-512.
Crossref
Crossref
Edward Michna, Wendy Y. Cheng, Caroline Korves, Howard Birnbaum, Ryan Andrews, Zhou Zhou, Ashish V. Joshi, David Schaaf, Jack Mardekian & Mei Sheng. (2014) Systematic Literature Review and Meta-Analysis of the Efficacy and Safety of Prescription Opioids, Including Abuse-Deterrent Formulations, in Non-Cancer Pain Management. Pain Medicine 15:1, pages 79-92.
Crossref
Crossref
Rajesh GuptaRajesh Gupta. 2014. Pain Management. Pain Management
99
100
.
Lynn R. Webster, Kieran A. Slevin, Arvind Narayana, Craig Q. Earl & Ronghua Yang. (2013) Fentanyl Buccal Tablet Compared with Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Cancer and Noncancer Pain: A Randomized, Double-Blind, Crossover Study Followed by a 12-Week Open-Label Phase to Evaluate Patient Outcomes. Pain Medicine 14:9, pages 1332-1345.
Crossref
Crossref
Jordi Guitart, Isabel Vargas, Vicente De Sanctis, Julia Ferreras, Jose Fuentes, Rafael Salazar, Juan M. Vázquez, Jordi Folch, Jordi Moya, Hermann Ribera, Francisco Rodelas, Albert Tomás, María Arilla, Joan Coma, Teresa Aberasturi, Dolores Sintes & Ester Lombán. (2013) Efficacy and Safety of Sublingual Fentanyl Orally Disintegrating Tablets in Patients with Breakthrough Pain: Multicentre Prospective Study. Clinical Drug Investigation 33:9, pages 675-683.
Crossref
Crossref
Luis Enrique Chaparro, Andrea D Furlan, Amol Deshpande, Angela Mailis-Gagnon, Steven Atlas & Dennis C Turk. (2013) Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Helmar Bornemann-Cimenti, Mischa Wejbora, Istvan S. Szilagyi & Andreas Sandner-Kiesling. (2013) Fentanyl for the Treatment of Tumor-Related Breakthrough Pain. Deutsches Ärzteblatt international.
Crossref
Crossref
R. Scharnagel, U. Kaiser, A. Schütze, R. Heineck, G. Gossrau & R. Sabatowski. (2013) Chronische nichttumorbedingte SchmerzenChronic non-cancer-related pain. Der Schmerz 27:1, pages 7-19.
Crossref
Crossref
Ingrid Schubert, Peter Ihle & Rainer Sabatowski. (2013) Increase in Opiate Prescription in Germany Between 2000 and 2010. Deutsches Ärzteblatt international.
Crossref
Crossref
Jörn Lötsch, Carmen Walter, Michael J. Parnham, Bruno G. Oertel & Gerd Geisslinger. (2012) Pharmacokinetics of Non-Intravenous Formulations of Fentanyl. Clinical Pharmacokinetics 52:1, pages 23-36.
Crossref
Crossref
Pascale Vergne-Salle, Françoise Laroche, Anne Bera-Louville, Marc Marty, Rose-Marie Javier & Serge Perrot. (2012) Les opioïdes forts dans les douleurs ostéo-articulaires non cancéreuses : revue de la littérature et recommandations pour la pratique clinique : « Les recommandations de Limoges 2010 ». Douleurs : Evaluation - Diagnostic - Traitement 13:6, pages 259-275.
Crossref
Crossref
Stephen V. Cantrill, Michael D. Brown, Russell J. Carlisle, Kathleen A. Delaney, Daniel P. Hays, Lewis S. Nelson, Robert E. O'Connor, AnnMarie Papa, Karl A. Sporer, Knox H. Todd & Rhonda R. Whitson. (2012) Clinical Policy: Critical Issues in the Prescribing of Opioids for Adult Patients in the Emergency Department. Annals of Emergency Medicine 60:4, pages 499-525.
Crossref
Crossref
Robert Twycross, Eric E. Prommer, Mary Mihalyo & Andrew Wilcock. (2012) Fentanyl (transmucosal). Journal of Pain and Symptom Management 44:1, pages 131-149.
Crossref
Crossref
Howard Smith. (2012) A Comprehensive Review of Rapid-Onset Opioids for Breakthrough Pain. CNS Drugs 26:6, pages 509-535.
Crossref
Crossref
David L. Saunders, John Messina, Mona Darwish, Fang Xie, Kevin J. Leary & Louis R. Cantilena. (2013) Assessment of the Relative Potency of Fentanyl Buccal Tablet to Intravenous Morphine in Healthy Volunteers Using a Thermally Induced Hyperalgesia Pain Model. The Journal of Clinical Pharmacology 52:6, pages 870-879.
Crossref
Crossref
Mona Darwish & Fang Xie. (2011) Pharmacokinetics of Fentanyl Buccal Tablet: A Pooled Analysis and Review. Pain Practice 12:4, pages 307-314.
Crossref
Crossref
Jerome Schofferman & Daniel Mazanec. 2012. Evidence-Based Management of Low Back Pain. Evidence-Based Management of Low Back Pain
154
170
.
Sebastiano Mercadante. (2011) Fentanyl buccal tablets for the treatment of breakthrough pain. Pain Management 1:6, pages 533-538.
Crossref
Crossref
Danielle Perret & Charles Rosen. (2011) A Physician-Driven Solution—The Association for Medical Ethics, The Physician Payment Sunshine Act, and Ethical Challenges in Pain Medicine. Pain Medicine 12:9, pages 1361-1375.
Crossref
Crossref
Michael A. Ashburn, Kieran A. Slevin, John Messina & Fang Xie. (2011) The Efficacy and Safety of Fentanyl Buccal Tablet Compared with Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain. Anesthesia & Analgesia 112:3, pages 693-702.
Crossref
Crossref
Steven D. Passik, John Messina, Anthony Golsorkhi & Fang Xie. (2011) Aberrant Drug-Related Behavior Observed During Clinical Studies Involving Patients Taking Chronic Opioid Therapy for Persistent Pain and Fentanyl Buccal Tablet for Breakthrough Pain. Journal of Pain and Symptom Management 41:1, pages 116-125.
Crossref
Crossref
Gagan Mahajan, Samir Sheth & Mark Holtsman. 2011. Essentials of Pain Medicine. Essentials of Pain Medicine
85
96
.
Perry G. Fine, John Messina, Fang Xie & James Rathmell. (2010) Long-Term Safety and Tolerability of Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain: An 18-Month Study. Journal of Pain and Symptom Management 40:5, pages 747-760.
Crossref
Crossref
John T. Farrar, John Messina, Fang Xie & Russell K. Portenoy. (2010) A Novel 12-Week Study, with Three Randomized, Double-Blind Placebo-Controlled Periods to Evaluate Fentanyl Buccal Tablets for the Relief of Breakthrough Pain in Opioid-Tolerant Patients with Noncancer-Related Chronic Pain. Pain Medicine 11:9, pages 1313-1327.
Crossref
Crossref
Perry G. Fine, Arvind Narayana & Steven D. Passik. (2010) Treatment of Breakthrough Pain with Fentanyl Buccal Tablet in Opioid-Tolerant Patients with Chronic Pain: Appropriate Patient Selection and Management. Pain Medicine 11:7, pages 1024-1036.
Crossref
Crossref
Mona Darwish, Mary Kirby, Philmore RobertsonJrJr, William Tracewell & Fang Xie. (2012) Dose Proportionality of Fentanyl Buccal Tablet in Doses Ranging from 600 to 1300μg in Healthy Adult Subjects. Clinical Drug Investigation 30:6, pages 365-373.
Crossref
Crossref
Sushma BhatnagarSurjya UpadhyaySeema Mishra. (2010) Prevalence and Characteristics of Breakthrough Pain in Patients with Head and Neck Cancer: A Cross-Sectional Study. Journal of Palliative Medicine 13:3, pages 291-295.
Crossref
Crossref
Mona DarwishEhab HamedJohn Messina. (2010) Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain: Pharmacokinetics of Buccal Mucosa Delivery and Clinical Efficacy. Perspectives in Medicinal Chemistry 4, pages PMC.S3928.
Crossref
Crossref
Sina Grape, Stephan A. Schug, Stefan Lauer & Barbara S. Schug. (2010) Formulations of Fentanyl for the Management of Pain. Drugs 70:1, pages 57-72.
Crossref
Crossref
Remigiusz LecybylMagdi Hanna. (2010) Breakthrough Pain: Focus on Fentanyl Buccal Tablet. Clinical Medicine Insights: Therapeutics 2, pages 1179559X1000200.
Crossref
Crossref
Steve N. Quessy. (2010) Two-stage enriched enrolment pain trials: A brief review of designs and opportunities for broader application. Pain 148:1, pages 8-13.
Crossref
Crossref
M. Marty. (2010) Prise en charge de la lombalgie chronique. EMC - Trait? de m?decine AKOS 5:4, pages 1-7.
Crossref
Crossref
J. Devulder, A. Jacobs, U. Richarz & H. Wiggett. (2009) Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain. British Journal of Anaesthesia 103:4, pages 576-585.
Crossref
Crossref
Lona Louring Christrup, Lena Lundorff & Mads Werner. (2009) Novel formulations and routes of administration for opioids in the treatment of breakthrough pain. Therapy 6:5, pages 695-706.
Crossref
Crossref
Perry G. Fine, Gagan Mahajan & Mary Lynn McPherson. (2009) Long-Acting Opioids and Short-Acting Opioids: Appropriate Use in Chronic Pain Management. Pain Medicine 10:suppl 2, pages S79-S88.
Crossref
Crossref
Steven P. Stanos, David A. Fishbain & Scott M. Fishman. (2009) Pain Management with Opioid Analgesics. American Journal of Physical Medicine & Rehabilitation 88:3, pages S69-S99.
Crossref
Crossref
Roger Chou, Gilbert J. Fanciullo, Perry G. Fine, Jeremy A. Adler, Jane C. Ballantyne, Pamela Davies, Marilee I. Donovan, David A. Fishbain, Kathy M. Foley, Jeffrey Fudin, Aaron M. Gilson, Alexander Kelter, Alexander Mauskop, Patrick G. O'Connor, Steven D. Passik, Gavril W. Pasternak, Russell K. Portenoy, Ben A. Rich, Richard G. Roberts, Knox H. Todd & Christine Miaskowski. (2009) Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. The Journal of Pain 10:2, pages 113-130.e22.
Crossref
Crossref
Roger Chou, Jane C. Ballantyne, Gilbert J. Fanciullo, Perry G. Fine & Christine Miaskowski. (2009) Research Gaps on Use of Opioids for Chronic Noncancer Pain: Findings From a Review of the Evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline. The Journal of Pain 10:2, pages 147-159.e15.
Crossref
Crossref
Neil A. Hagen, Patricia Biondo & Carla Stiles. (2008) Assessment and management of breakthrough pain in cancer patients: Current approaches and emerging research. Current Pain and Headache Reports 12:4, pages 241-248.
Crossref
Crossref
Jane C. Ballantyne & Naomi S. Shin. (2008) Efficacy of Opioids for Chronic Pain. The Clinical Journal of Pain 24:6, pages 469-478.
Crossref
Crossref
Clifford Gevirtz. (2008) Fentanyl Face-Off. Topics in Pain Management 23:12, pages 1-5.
Crossref
Crossref
Phillip Good & Fang Xie. (2008) Analysis of a crossover clinical trial by permutation methods. Contemporary Clinical Trials 29:4, pages 565-568.
Crossref
Crossref
Christopher A. Hulen. (2008) Nonoperative Treatment of Low Back Pain. Seminars in Spine Surgery 20:2, pages 102-112.
Crossref
Crossref
Warren A. Katz. (2008) Opioids for Nonmalignant Pain. Rheumatic Disease Clinics of North America 34:2, pages 387-413.
Crossref
Crossref
Elliot V. Hersh, Ramesh Balasubramaniam & Andres Pinto. (2008) Pharmacologic Management of Temporomandibular Disorders. Oral and Maxillofacial Surgery Clinics of North America 20:2, pages 197-210.
Crossref
Crossref
S. Donnadieu. (2008) Douleurs induites par les soins chez les personnes âgées. Douleurs : Evaluation - Diagnostic - Traitement 9:1, pages 22-27.
Crossref
Crossref
Leeroy William & Rod MacLeod. (2008) Management of Breakthrough Pain in Patients with Cancer. Drugs 68:7, pages 913-924.
Crossref
Crossref
Teijo I. Saari, Kari Laine, Mikko Neuvonen, Pertti J. Neuvonen & Klaus T. Olkkola. (2007) Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl. European Journal of Clinical Pharmacology 64:1, pages 25-30.
Crossref
Crossref
S. Donnadieu. (2007) Prévention et soulagement des douleurs induites par les soins en ORL. Annales d'Otolaryngologie et de Chirurgie Cervico-faciale 124, pages S23-S27.
Crossref
Crossref
Remigiusz LecybylMagdi Hanna. (2007) Fentanyl buccal tablet: faster rescue analgesia for breakthrough pain?. Future Oncology 3:4, pages 375-379.
Crossref
Crossref
Amol Deshpande, Andrea D Furlan, Angela Mailis-Gagnon, Steven Atlas & Denis Turk. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
David M. Simpson, John Messina, Fang Xie & Martin Hale. (2007) Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Clinical Therapeutics 29:4, pages 588-601.
Crossref
Crossref